SCHEMBL143545

SCHEMBL143545

FC(F)(F)C(F)(F)C(F)(F)N1CCOCC1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.33
MGLL Q99685 1/20 0.31
TTR P02766 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9446885 0.91 MAPT (0.31) MAPT
SCHEMBL9446872 0.91 MAPT (0.31) MAPT
SCHEMBL9371699 0.91 MAPT (0.31) MAPT
SCHEMBL9370743 0.87 MGLL (0.32) MAPTMGLL
SCHEMBL6759923 0.84 MAPT (0.34) MAPTMGLL
SCHEMBL8605916 0.80 MAPT (0.33) MAPTMGLL
SCHEMBL8606247 0.78 MAPT (0.32) MAPT
SCHEMBL23667244 0.78 MAPT (0.33) MAPT
SCHEMBL23667237 0.78 MAPT (0.33) MAPT
SCHEMBL19191005 0.76 MAPT (0.30) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120058588-A1 DEVICE AND METHOD FOR SIMULTANEOUSLY MICROSTRUCTURING AND DOPING SEMICONDUCTOR SUBSTRATES FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2012-03-08 US claimed
EP-2403679-A2 DEVICE AND METHOD FOR SIMULTANEOUSLY MICROSTRUCTURING AND DOPING SEMICONDUCTOR SUBSTRATES Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2012-01-11 EP claimed
WO-2010099862-A2 DEVICE AND METHOD FOR SIMULTANEOUSLY MICROSTRUCTURING AND DOPING SEMICONDUCTOR SUBSTRATES Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2010-09-10 WO claimed
US-12398223-B2 Method for producing fluororesin particles TOSOH CORPORATION (JP) 2025-08-26 US disclosed
CN-116217762-B Fluororesin, process for producing the same, and process for producing fluororesin particles 东曹株式会社 2024-09-20 CN disclosed
US-20240141081-A1 FLUORORESIN, AND METHOD FOR PRODUCING SAME TOSOH CORPORATION (JP) 2024-05-02 US disclosed
CN-115677887-B Fluororesin, process for producing the same, and process for producing fluororesin particles 东曹株式会社 2024-03-08 CN disclosed
CN-116217762-A Fluororesin, process for producing the same, and process for producing fluororesin particles 东曹株式会社 2023-06-06 CN disclosed
CN-115677887-A Fluororesin, process for producing the same, and process for producing fluororesin particles 东曹株式会社 2023-02-03 CN disclosed
US-20210380735-A1 FLUORORESIN, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING FLUORORESIN PARTICLES TOSOH CORPORATION (JP) 2021-12-09 US disclosed
EP-3865521-A1 FLUORORESIN, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING FLUORORESIN PARTICLES Tosoh Corporation (JP) 2021-08-18 EP disclosed
CN-112805308-A Fluororesin, method for producing same, and method for producing fluororesin particles 东曹株式会社 2021-05-14 CN disclosed
US-20120058588-A1 DEVICE AND METHOD FOR SIMULTANEOUSLY MICROSTRUCTURING AND DOPING SEMICONDUCTOR SUBSTRATES FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058588-A1 DEVICE AND METHOD FOR SIMULTANEOUSLY MICROSTRUCTURING AND DOPING SEMICONDUCTOR SUBSTRATES BRSK1, BOD1L1, DUSP6 MAPT 1467/4885MGLL 3246/4885TTR 3714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.